The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001–03

Abstract

Buprenorphine prescribing has increased dramatically and represents a disproportionately large fraction of community opiate prescribing costs. The marked regional variation suggests the need for further research and the development of national guidelines to support rational prescribing and equitable access to treatment.